<DOC>
	<DOCNO>NCT02792673</DOCNO>
	<brief_summary>The study design prospective randomize uncontrolled clinical trial . It include 150 case . The aim study compare efficacy three different medium use embryo transfer regard `` chemical clinical '' pregnancy rate , implantation rate ongoing pregnancy miscarriage rate IVF ICSI cycle . The three different embryo transfer medium : 1 . Hyaluronan-enriched medium `` Embryo Glue® '' 2 . 30 % Protein-supplemented Culture medium `` Global Total® '' 3 . Autologous Follicular Fluid ( Novel technique ) In order establish optimal medium embryo transfer</brief_summary>
	<brief_title>Comparative Study Three Different Embryo Transfer Media ICSI Cycles</brief_title>
	<detailed_description>Two three embryo transfer day 5 ovum pick-up ( OPU ) . The patient divide randomly ( closed envelop method ) 3 group : - Group A ( 50 patient ) : embryo transfer use medium supplement 0.5 mg/mL hyaluronic acid ( EmbryoGlue® , Vitrolife , Sweden ) 20 minute intrauterine transfer take place - Group B ( 50 patient ) : embryo transfer use medium 30 % Protein-supplemented Culture Medium ( Global total® , Life Global group , Canada ) 20 minute . - Group C ( 50 patient ) : novel technique embryo transfer use medium autologous Follicular Fluid 20 minute . Follicular fluid collect sterile procedure , centrifuge 20 minute embryo test tube . The supernatant remove sterilize technique heat 56°C 30 minute filter 0.22 micron filter . Gentamycin sulphate add concentration 10 µg/mL liquid preserve normal freezer . Defreezing follicular fluid perform day-1 embryo transfer . The follicular fluid warm room temperature . Preparation embryo transfer medium perform usual , covered paraffin oil ( Ovoil® , Vitrolife , Sweeden ) incubate overnight 7 % CO2 , 9 % O2 , 22 % N2 . All embryo transfer perform use embryo transfer catheter ( Labotect catheter , Labotect GmbH , Germany ) . Number embryo transfer accord ASRM guideline 2013 day 5 ovum pick-up ( OPU ) .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Age : 1835 year 2 . Body mass index ( BMI ) : ≤ 30 3 . Antimullerian hormone ( AMH ) : 1.1 3 4 . No gynecological problem e.g . fibroid , endometriosis , uterine polyp , hydrosalpinx adenomysis 5 . Male factor : mild moderate oligo asthenospermia 1 . Age : &lt; 18 year &gt; 35 year 2 . Body mass index ( BMI ) : &gt; 30 3 . Antimullerian hormone ( AMH ) : &lt; 1.1 &gt; 3 4. gynecological problem e.g . fibroid , endometriosis , uterine polyp , hydrosalpinx adenomysis exclude 5 . Male factor : Abnormal sperm morphology ; ( globozoospermia pinpoint sperm ) azoospermia ; ( whether obstructive nonobstructive ) exclude 6 . Patients recurrent implantation failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Embryo transfer medium</keyword>
	<keyword>improvement embryo transfer technique</keyword>
	<keyword>improvement implantation</keyword>
	<keyword>Hyaluronan-enriched medium `` Embryo Glue® ''</keyword>
	<keyword>30 % Protein-supplemented Culture Medium `` Global Total® ''</keyword>
	<keyword>Autologous Follicular Fluid embryo transfer medium</keyword>
</DOC>